DocSym
β
Searchsearch
Search
(G37.9) Demyelinating disease of central nervous system, unspecified
More details coming soon
549 735 in individuals diagnosis demyelinating disease of central nervous system, unspecified confirmed
10 580 deaths with diagnosis demyelinating disease of central nervous system, unspecified
2% mortality rate associated with the disease demyelinating disease of central nervous system, unspecified
Diagnosis demyelinating disease of central nervous system, unspecified is diagnosed Women are 28.32% more likely than Men
197 036
Men receive the diagnosis demyelinating disease of central nervous system, unspecified
5 942 (3.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
352 699
Women receive the diagnosis demyelinating disease of central nervous system, unspecified
4 638 (1.3 %)Died from this diagnosis.
Risk Group for the Disease demyelinating disease of central nervous system, unspecified - Men aged 30-34 and Women aged 35-39
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features demyelinating disease of central nervous system, unspecified
Absence or low individual and public risk
Demyelinating disease of central nervous system, unspecified - what does this mean
Demyelinating diseases of the central nervous system (cns) are conditions in which the myelin sheath, which insulates and protects the nerve cells, is damaged or destroyed. this damage can be caused by an autoimmune response, genetic mutation, infection, or environmental factors. the resulting damage can lead to a variety of neurological symptoms, depending on which areas of the cns are affected.
What happens during the disease - demyelinating disease of central nervous system, unspecified
Demyelinating diseases of the central nervous system are caused by the destruction of the myelin sheath, which is a protective layer that surrounds the nerve cells. this destruction can be caused by an autoimmune disorder, infection, or other unknown factors. the destruction of the myelin sheath disrupts the transmission of electrical signals between the brain and the rest of the body, resulting in a wide range of neurological symptoms.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical exam to assess neurological symptoms
- Blood tests to look for signs of infection or inflammation
- Imaging tests such as an MRI scan to look for abnormalities in the brain or spinal cord
- Lumbar puncture to analyze cerebrospinal fluid
- Nerve conduction studies to measure the speed of nerve signals
- Electromyography to measure muscle activity
- Evoked potentials to measure the electrical activity of the brain in response to sensory stimulation
Treatment and Medical Assistance
Main goal: To reduce the symptoms of demyelinating disease of the central nervous system.
- Prescribe medications to reduce inflammation and pain.
- Provide physical therapy to help with mobility.
- Encourage healthy lifestyle habits such as exercise and nutrition.
- Refer to specialists for further diagnosis and treatment.
- Provide counseling to address emotional and mental health issues.
- Educate patient and family on the disease and its management.
- Monitor progress and adjust treatment plan as needed.
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Demyelinating disease of central nervous system, unspecified - Prevention
Demyelinating disease of the central nervous system, unspecified, can be prevented by reducing risk factors such as smoking, exposure to certain toxins, and autoimmune diseases; maintaining a healthy diet and lifestyle; and avoiding contact with people who have active cases of the disease. vaccines may also be available to help prevent certain types of demyelinating diseases.